Palivizumab, a monoclonal antibody is used for the prophylaxis of:
Ans. (D) Respiratory syncytial virus(Katzung 13th/863)Palivizumab is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of respiratory syncytial virus (RSV) infections.
Human metapneumovirus
Para-influenza virus type 2 and 4
Influenza virus
Respiratory syncytial virus
Immunomodulatory: DMARDS, Monoclonal Antibodies